Recruiting
Phase 2

Gemcitabine & Cisplatin

Sponsor:

Alliance for Clinical Trials in Oncology

Code:

NCT03609216

Conditions

Infiltrating Bladder Urothelial Carcinoma

Stage II Bladder Urothelial Carcinoma

Stage III Bladder Urothelial Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Gemcitabine Hydrochloride

Cisplatin

Pegfilgrastim

Conventional Surgery

Radical Cystectomy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information